Immunotherapy of Peritoneal Carcinomatosis with Catumaxomab

被引：0
|
作者：
Parsons, Simon L. [1 ]
机构：
[1] Nottingham Univ Hosp NHS Trust, Nottingham NG5 1PB, England
来源：
ONKOLOGIE | 2011年 / 34卷 / 03期
关键词：
CANCERS;
D O I：
10.1159/000324793
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 87
页数：2
相关论文
共 50 条
  • [1] Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab
    Goere, Diane
    Gras-Chaput, Nathalie
    Auperin, Anne
    Flament, Caroline
    Mariette, Christophe
    Glehen, Olivier
    Zitvogel, Laurence
    Elias, Dominique
    BMC CANCER, 2014, 14
  • [2] Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab
    Diane Goéré
    Nathalie Gras-Chaput
    Anne Aupérin
    Caroline Flament
    Christophe Mariette
    Olivier Glehen
    Laurence Zitvogel
    Dominique Elias
    BMC Cancer, 14
  • [3] The trifunctional antibody catumaxomab in treatment of malignant ascites and peritoneal carcinomatosis
    Stroehlein, Michael A.
    Heiss, Markus M.
    FUTURE ONCOLOGY, 2010, 6 (09) : 1387 - 1394
  • [4] Intraperitoneal immunotherapy of peritoneal carcinomatosis
    Freedman, RS
    Lenzi, R
    Kudelka, AP
    Lawrence, DD
    Rosenblum, M
    Platsoucas, CD
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 1998, 4 (02) : 121 - 140
  • [5] The current status of immunotherapy in peritoneal carcinomatosis
    Stroehlein, Michael Alfred
    Heiss, Markus Maria
    Jauch, Karl-Walter
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (10) : 1019 - 1027
  • [6] Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial
    Stroehlein, Michael A.
    Lordick, Florian
    Ruettinger, Dominik
    Gruetzner, Klaus-Uwe
    Schemanski, Oliver C.
    Jaeger, Michael
    Lindhofer, Horst
    Hennig, Michael
    Jauch, Karl-Walter
    Peschel, Christian
    Heiss, Markus M.
    ONKOLOGIE, 2011, 34 (03): : 101 - 108
  • [7] The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis
    Bella, Angela
    Melero, Ignacio
    Berraondo, Pedro
    Aranda, Fernando
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [8] Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes
    Ornella, Mefotse Saha Cyrelle
    Badrinath, Narayanasamy
    Kim, Kyeong-Ae
    Kim, Jung Hee
    Cho, Euna
    Hwang, Tae-Ho
    Kim, Jae-Joon
    CANCERS, 2023, 15 (08)
  • [9] ROLE OF MACROPHAGES IN THE IMMUNOTHERAPY OF LEWIS LUNG PERITONEAL CARCINOMATOSIS
    WALLACE, PK
    MORAHAN, PS
    JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 56 (01) : 41 - 51
  • [10] Results of the CARMA study to investigate catumaxomab therapy for ascites related to peritoneal carcinomatosis in clinical practice
    Kurbacher, Christian M.
    Sehouli, Jalid
    Welslau, Manfred
    Tempelhoff, G. -F.
    Kufahl, J.
    Marth, Christian
    Oettle, Helmut
    Schmalfeldt, Barbara
    Urban, Elisabeth
    Kunzmann, Volker
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345